Jamaican Support Urged for Anti-Smoking Campaign Starting Next Year

Regulations by 2FIRSTS.ai
Dec.25.2023
Jamaican Support Urged for Anti-Smoking Campaign Starting Next Year
Jamaican Observer reports that a recent study by the NCDA suggests support for anti-smoking campaigns due to the rise of e-cigarette use among Jamaican youth.

The Jamaica Observer reported on December 24th that according to the National Council on Drug Abuse (NCDA), recent research on e-cigarettes suggests that Jamaicans should support the agency's upcoming anti-smoking campaign set to commence next year.

 

Ms. Qi Atkinson, a research analyst at the National Center for Drug Abuse (NCDA), has stated that a study conducted over the past two months using three counties as samples has found that e-cigarettes have become a trend among elementary and high school students. This research was prompted by an increasing number of reports on e-cigarettes in schools across the entire island. Experts have highlighted the harmful effects of smoking on health and well-being.

 

In reality, it is not uncommon for high school students to smoke. In fact, many of today's adult smokers picked up this unhealthy habit back in their high school days, putting themselves among the more than five million people who die each year from direct smoking. Smoking or being exposed to secondhand smoke can lead to cardiovascular and respiratory diseases, including coronary heart disease and lung cancer. Medical experts also point out that secondhand smoke may cause sudden infant death syndrome and low birth weight in babies born to pregnant women exposed to smoke.

 

Ms. Atkinson stated, "We already know that e-cigarettes are gaining popularity, but the information directly obtained from the respondents does confirm the increasing issues we are facing." According to Ms. Atkinson, research has found that due to the marketing appeal of various flavored products, which the tobacco industry claims can reduce the harm of smoking, students have a very low perception of the risks associated with e-cigarettes. Consequently, for these students, "e-cigarettes are seen as cool," and their easy accessibility further exacerbates this problem.

 

However, the harsh reality is that research has shown that the vapor from e-cigarettes typically contains nicotine and other toxic substances that are harmful to both users and those exposed to secondhand smoke. Even products labeled as "nicotine-free" actually contain highly addictive nicotine.

 

According to a study conducted by the NCDA, the intake of nicotine by children and adolescents can have an impact on brain development and may lead to learning and anxiety disorders. Additionally, it has been found that accidental exposure to the e-liquid in e-cigarettes among children can pose serious risks, as these devices may leak. The harmful effects of these products on health are evident. Therefore, it is not surprising that the World Health Organization has called for a global ban on all flavored e-cigarettes, treating them on par with traditional cigarettes.

 

Ms. Atkinson believes that the pressing concern in Jamaica is the protection of children, as young people are struggling with their mental health and learning to cope with life. If urgent attention is not paid to them, there will be significant issues in the future.

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

PMI Expands U.S. ZYN Portfolio With New 1.5 mg and 8 mg Strengths, Moves Toward a Unified 20-Pouch-Per-Can Format
PMI Expands U.S. ZYN Portfolio With New 1.5 mg and 8 mg Strengths, Moves Toward a Unified 20-Pouch-Per-Can Format
Philip Morris International is expanding its U.S. ZYN nicotine pouch portfolio with new 1.5 mg and 8 mg strengths and plans to move its core 3 mg and 6 mg dry-pouch products from 15 to 20 pouches per can in the fourth quarter of 2026. ZYN ULTRA is also commercially available, with FDA authorization covering 10 products at 9 mg and one 11 mg Smooth product. PMI U.S. lists the new 1.5 mg and 8 mg strengths as commercially available, but as of September 10 they do not appear on the FDA’s public authorization list. Public materials do not identify which PMTA submissions cover the two new strengths or their current review status.
Sep.11
FDA Unifies Tobacco Registration and Product Listing Form Across Product Categories
FDA Unifies Tobacco Registration and Product Listing Form Across Product Categories
The U.S. FDA has consolidated two tobacco establishment registration and product listing forms into a redesigned Form FDA 3741 covering all regulated product categories, including e-cigarettes, heated tobacco products and nicotine pouches. The current requirements remain limited to domestic establishments. Separately, the FDA has proposed extending registration and product listing requirements to foreign manufacturers, signaling greater regulatory attention to manufacturing entities and product-level information across the tobacco and nicotine supply chain.
FDA
Sep.30
Product | PIXL Adds 6ml PIXL 5K in UK Alongside 12ml PIXL 8000 as Vape Duty Takes Effect
Product | PIXL Adds 6ml PIXL 5K in UK Alongside 12ml PIXL 8000 as Vape Duty Takes Effect
Vaping brand PIXL has introduced the PIXL 5K reusable prefilled pod device in the UK, featuring a 2ml prefilled pod and a 4ml refill container with a combined e-liquid capacity of 6ml. The device uses 20mg/ml nicotine salt e-liquid and is advertised to deliver up to approximately 5,000 puffs. Available through UK retailers by August 2026, the PIXL 5K sits alongside the existing 12ml PIXL 8000. The UK's Vaping Products Duty took effect on October 1 at £0.22 per millilitre, producing theoretical duty amounts of £1.32 and £2.64 for the two products' respective full refill sets.
product
Oct.10
New Zealand Associate Health Minister Casey Costello Warns on Illicit Cigarettes as Legal Tobacco Sales Halve Over Decade
New Zealand Associate Health Minister Casey Costello Warns on Illicit Cigarettes as Legal Tobacco Sales Halve Over Decade
New Zealand Associate Health Minister Casey Costello said legal tobacco sales in the country have fallen by more than half over the past decade, with sales declining more than 20% in 2025 compared with the previous year. She warned that the decline may not fully reflect lower smoking rates, as increased availability of illicit cigarettes could also be contributing. The government said it would continue strengthening tobacco and vape retail enforcement while monitoring the impact of illicit tobacco on public health and tax revenue.
Aug.26
Product | IVG Launches NEXiO Prefilled Pod System, Expanding Beyond Disposable Vapes
Product | IVG Launches NEXiO Prefilled Pod System, Expanding Beyond Disposable Vapes
UK vape brand IVG has launched the NEXiO reusable prefilled pod system, expanding its product portfolio beyond disposable vape products. The device features a 1,000mAh rechargeable battery, prefilled pods with a refill reservoir structure and a claimed capacity of up to 10,000 puffs. Officially launched in the UK on July 9, 2026, NEXiO debuted with 17 flavor options, reflecting IVG’s move into reusable pod formats.
Aug.19
Australia Adds 6-Methylnicotine to Schedule 9 Prohibited Substances, Effective October 1
Australia Adds 6-Methylnicotine to Schedule 9 Prohibited Substances, Effective October 1
Australia's Therapeutic Goods Administration published a final decision on September 25 to classify 6-methylnicotine as a Schedule 9 prohibited substance under the Poisons Standard, effective October 1, 2026. TGA said the chemical has been reported in e-cigarette liquids sold in Australia and marketed as nicotine-free or nicotine alternatives, while evidence also indicates its use in preparations such as oral pouches. The government originally proposed a Schedule 7 classification but ultimately adopted the stricter Schedule 9 designation, citing acute toxicity, dependence risk, use in unapproved consumer products and misleading marketing.
News
Sep.29 by 2Firsts Perspectives